Assembly and Validation of Versatile Transcription Activator-Like Effector Libraries

被引:6
|
作者
Li, Yi [1 ]
Ehrhardt, Kristina [1 ,2 ]
Zhang, Michael Q. [2 ,3 ]
Bleris, Leonidas [1 ,2 ,4 ]
机构
[1] Univ Texas Dallas, Bioengn Dept, Richardson, TX 75080 USA
[2] Univ Texas Dallas, Ctr Syst Biol, Richardson, TX 75080 USA
[3] Univ Texas Dallas, Mol & Cell Biol Dept, Richardson, TX 75080 USA
[4] Univ Texas Dallas, Dept Elect Engn, Richardson, TX 75080 USA
来源
SCIENTIFIC REPORTS | 2014年 / 4卷
基金
美国国家卫生研究院; 美国国家科学基金会;
关键词
HUMAN GENOME; DNA; RNAI; GENE; RECOGNITION; TALEN; CONSTRUCTION; SPECIFICITY; RESISTANCE; NUCLEASES;
D O I
10.1038/srep04857
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The ability to perturb individual genes in genome-wide experiments has been instrumental in unraveling cellular and disease properties. Here we introduce, describe the assembly, and demonstrate the use of comprehensive and versatile transcription activator-like effector (TALE) libraries. As a proof of principle, we built an 11-mer library that covers all possible combinations of the nucleotides that determine the TALE-DNA binding specificity. We demonstrate the versatility of the methodology by constructing a constraint library, customized to bind to a known p53 motif. To verify the functionality in assays, we applied the 11-mer library in yeast-one-hybrid screens to discover TALEs that activate human SCN9A and miR-34b respectively. Additionally, we performed a genome-wide screen using the complete 11-mer library to confirm known genes that confer cycloheximide resistance in yeast. Considering the highly modular nature of TALEs and the versatility and ease of constructing these libraries we envision broad implications for high-throughput genomic assays.
引用
收藏
页数:7
相关论文
共 50 条
  • [31] Improved Somatic Mutagenesis in Zebrafish Using Transcription Activator-Like Effector Nucleases (TALENs)
    Moore, Finola E.
    Reyon, Deepak
    Sander, Jeffry D.
    Martinez, Sarah A.
    Blackburn, Jessica S.
    Khayter, Cyd
    Ramirez, Cherie L.
    Joung, J. Keith
    Langenau, David M.
    PLOS ONE, 2012, 7 (05):
  • [32] Rh D blood group conversion using transcription activator-like effector nucleases
    Kim, Young-Hoon
    Kim, Hyun O.
    Baek, Eun J.
    Kurita, Ryo
    Cha, Hyuk-Jin
    Nakamura, Yukio
    Kim, Hyongbum
    NATURE COMMUNICATIONS, 2015, 6
  • [33] Rh D blood group conversion using transcription activator-like effector nucleases
    Young-Hoon Kim
    Hyun O. Kim
    Eun J. Baek
    Ryo Kurita
    Hyuk-Jin Cha
    Yukio Nakamura
    Hyongbum Kim
    Nature Communications, 6
  • [34] Transcription activator-like effector hybrids for conditional control and rewiring of chromosomal transgene expression
    Yi Li
    Richard Moore
    Michael Guinn
    Leonidas Bleris
    Scientific Reports, 2
  • [35] Targeted Mutagenesis of the Tomato PROCERA Gene Using Transcription Activator-Like Effector Nucleases
    Lor, Vai S.
    Starker, Colby G.
    Voytas, Daniel F.
    Weiss, David
    Olszewski, Neil E.
    PLANT PHYSIOLOGY, 2014, 166 (03) : 1288 - +
  • [36] Transcription activator-like effector hybrids for conditional control and rewiring of chromosomal transgene expression
    Li, Yi
    Moore, Richard
    Guinn, Michael
    Bleris, Leonidas
    SCIENTIFIC REPORTS, 2012, 2
  • [37] Transcription activator-like effector nucleases (TALENs): An efficient tool for plant genome editing
    Chaudhary, Kulbhushan
    Pratap, Dharmendra
    Sharma, Pradeep K.
    ENGINEERING IN LIFE SCIENCES, 2016, 16 (04): : 330 - 337
  • [38] The application of transcription activator-like effector nucleases for genome editing in C-elegans
    Yi, Peishan
    Li, Wei
    Ou, Guangshuo
    METHODS, 2014, 68 (03) : 389 - 396
  • [39] Genome Editing in Astyanax mexicanus Using Transcription Activator-like Effector Nucleases (TALENs)
    Kowalko, Johanna E.
    Ma, Li
    Jeffery, William R.
    JOVE-JOURNAL OF VISUALIZED EXPERIMENTS, 2016, (112):
  • [40] Transcription Activator-Like Effector (TALE) Nucleases and Repressor TALEs for Antiviral Gene Therapy
    Bloom K.
    Mussolino C.
    Arbuthnot P.
    Current Stem Cell Reports, 2015, 1 (1) : 1 - 8